NFE2L2 and central nervous system cancer: As expected, we found that overexpression of HACE1 in glioma cells substantially enhanced the ability of cell proliferation and invasiveness compared with the control, and these effects were effectively attenuated upon NRF2 knockdown (Supplementary Fig. S8).